Deerfield Management Discloses Stake in Post-IPO Auspex Pharmaceuticals Inc (ASPX)

James E. Flynn‘s Deerfield Management has revealed holding shares of Auspex Pharmaceuticals Inc (NASDAQ:ASPX), a company that went public today, on February 5. Deerfield reported ownership of around 1.29 million common shares, held via class E preferred stock. The securities can be converted into shares of common stock on the basis of 0.222 shares of Common Stock per one unit of Preferred Stock.

Auspex

According to the terms of the IPO, Auspex Pharmaceuticals Inc (NASDAQ:ASPX) intended to sell 6.0 million shares at a price of $12 apiece. In this way following the IPO, the preferred stock of the company will be converted and the total amount of outstanding shares amounts to around 21.53 million. The net proceeds from the offering are planned to be used for the development of Auspex’s SD-809, a novel drug discovered by the company, and for which it holds worldwide rights. The drug is the main product of the company, and since it has not been approved by the FDA it represents a major risk that will severely impact Auspex Pharmaceuticals Inc (NASDAQ:ASPX)’s business.

Despite the risk associated with the weak financial results and the company’s dependence on a single product, the IPO was well received by the market, the stock of Auspex Pharmaceuticals Inc (NASDAQ:ASPX) gaining around 18% in the morning trading.

Aside from Auspex Pharmaceuticals Inc (NASDAQ:ASPX), Deerfield reported recently about another biopharmaceutical “emerging growth” company that went public a couple of days ago, Dicerna Pharmaceuticals Inc (NASDAQ:DRNA). The fund reported holding around 2.12 million shares, which have been obtained through the conversion of the preferred stock held previously to the IPO and the acquisition of additional units of common stock.

Both investments disclosed lately by Deerfield, Auspex Pharmaceuticals Inc (NASDAQ:ASPX) and Dicerna come in line with the fund’s targets. Deerfield prefers to focus on healthcare companies and funds Research & Development among other things.

Disclosure: none

Recommended Reading:

Deerfield Management & Brookside Capital Revealed Significant Stakes in Newly Public Dicerna Pharmaceuticals Inc (DRNA)

Sanford J. Colen’s Apex Capital’s Top Picks Include Netflix, Inc. (NFLX) & eBay Inc (EBAY) Among Others

Michael Messner’s Seminole Capital Top Picks From the Latest 13F

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Cheapest Cities to Visit in the US

Most Expensive Summer Camps

Most Expensive Animals in the World

Most Expensive Specialty Crops in the World

Movies That Took Ages to Make

The Longest Hollywood Films Ever Made

Most Expensive Concert Stages

The Richest Bands of all Time

10 Most Corrupt Countries 2013 List

10 Countries with the Highest Quality of Life Index

Most Expensive Mattresses in the World

5 Smallest Countries by Land Area

The Ultimate Heartbreak Songs

Richest Teenagers in the World

10 Most Haunted Places in America

10 Best Places to Retire in Florida East Coast

Top 10 Places to See Before You Die

Top 8 Countries in the World Where Justice Prevails

10 Richest States in America

15 Wealthiest Countries in the World

Richest Singers in the World

Most Expensive Tasting Menu in New York City

Most Expensive Baby Items in the World

Most Expensive Hotel Suites in Vegas

Most Expensive Brunch in New York City

Most Expensive Beef Cuts in the World

25 Best Colleges to Get a Job

Top 10 US Supermarkets

The 25 Most Dangerous Cities in the World to Visit

Most Expensive Xbox Games

Top 11 Cities Where Billionaires Live

Top 10 Most Charitable Companies in America

Most Expensive Seafood in the World

The 10 Wildest Conspiracy Theories

The 10 Best Job Markets in the US

Top 10 Accounting Scandals of All Time

The 25 Biggest Cities in the World

Top 10 Best Paying Virtual Jobs

Most Expensive Leather Shoes in the World

Top 6 Things to Buy in March

The 10 Most Stressful Jobs in America – 2014 List

Top 10 Jobs for Introverted People

Top 10 Honeymoon Destinations in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!